2.56
price up icon1.59%   0.04
after-market Dopo l'orario di chiusura: 2.60 0.04 +1.56%
loading
Precedente Chiudi:
$2.52
Aprire:
$2.65
Volume 24 ore:
1.24M
Relative Volume:
1.19
Capitalizzazione di mercato:
$277.33M
Reddito:
$27.08M
Utile/perdita netta:
$-37.00M
Rapporto P/E:
-4.9231
EPS:
-0.52
Flusso di cassa netto:
$-18.46M
1 W Prestazione:
+9.40%
1M Prestazione:
+37.63%
6M Prestazione:
+77.78%
1 anno Prestazione:
+22.49%
Intervallo 1D:
Value
$2.40
$2.70
Intervallo di 1 settimana:
Value
$2.24
$2.70
Portata 52W:
Value
$1.05
$5.17

Aclaris Therapeutics Inc Stock (ACRS) Company Profile

Name
Nome
Aclaris Therapeutics Inc
Name
Telefono
484-324-7933
Name
Indirizzo
701 LEE ROAD, WAYNE, PA
Name
Dipendente
64
Name
Cinguettio
@aclaristx
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
ACRS's Discussions on Twitter

Confronta ACRS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACRS
Aclaris Therapeutics Inc
2.56 273.00M 27.08M -37.00M -18.46M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Ripresa Piper Sandler Overweight
2025-05-28 Iniziato Wedbush Outperform
2025-03-18 Ripresa Cantor Fitzgerald Overweight
2024-12-23 Aggiornamento H.C. Wainwright Neutral → Buy
2024-11-20 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2024-11-19 Aggiornamento BTIG Research Neutral → Buy
2024-11-19 Aggiornamento Jefferies Hold → Buy
2024-11-19 Aggiornamento Leerink Partners Market Perform → Outperform
2024-11-18 Aggiornamento Piper Sandler Neutral → Overweight
2024-01-22 Downgrade H.C. Wainwright Buy → Neutral
2023-11-13 Downgrade William Blair Outperform → Mkt Perform
2023-10-03 Iniziato Evercore ISI Outperform
2022-12-14 Iniziato Stifel Buy
2022-12-01 Iniziato Goldman Buy
2022-10-06 Iniziato BTIG Research Buy
2021-07-23 Ripresa Jefferies Buy
2021-06-15 Iniziato Piper Sandler Overweight
2021-04-21 Iniziato H.C. Wainwright Buy
2019-10-22 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-09-06 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-06-27 Downgrade SVB Leerink Outperform → Mkt Perform
2019-05-06 Iniziato SVB Leerink Outperform
2018-03-28 Ripresa Leerink Partners Outperform
2018-02-09 Iniziato Guggenheim Buy
2017-06-16 Iniziato Cantor Fitzgerald Overweight
2016-11-29 Iniziato Leerink Partners Outperform
2016-09-30 Iniziato JMP Securities Mkt Outperform
2016-06-10 Iniziato Guggenheim Buy
2015-11-02 Iniziato Citigroup Buy
2015-11-02 Iniziato Jefferies Buy
Mostra tutto

Aclaris Therapeutics Inc Borsa (ACRS) Ultime notizie

pulisher
10:03 AM

Will Aclaris Therapeutics Inc. stock outperform international peersTrade Ideas & Risk Managed Investment Entry Signals - newser.com

10:03 AM
pulisher
10:03 AM

Key resistance and support levels for Aclaris Therapeutics Inc.2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com

10:03 AM
pulisher
09:53 AM

Understanding Aclaris Therapeutics Inc.’s price movement2025 Top Gainers & High Yield Stock Recommendations - newser.com

09:53 AM
pulisher
07:50 AM

Applying chart zones and confluence areas to Aclaris Therapeutics Inc.Dollar Strength & AI Enhanced Execution Alerts - newser.com

07:50 AM
pulisher
07:41 AM

Will Aclaris Therapeutics Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - newser.com

07:41 AM
pulisher
06:13 AM

Can Aclaris Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com

06:13 AM
pulisher
05:48 AM

Risk adjusted return profile for Aclaris Therapeutics Inc. analyzedStop Loss & Fast Momentum Entry Tips - newser.com

05:48 AM
pulisher
05:02 AM

Statistical indicators supporting Aclaris Therapeutics Inc.’s strengthWatch List & Long Hold Capital Preservation Plans - newser.com

05:02 AM
pulisher
04:54 AM

Why Aclaris Therapeutics Inc. (8AT) stock is a must watch tickerPortfolio Update Summary & AI Forecasted Stock Moves - newser.com

04:54 AM
pulisher
03:42 AM

Why Aclaris Therapeutics Inc. (8AT) stock gets analyst attentionPortfolio Update Report & Proven Capital Preservation Methods - newser.com

03:42 AM
pulisher
02:41 AM

Will Aclaris Therapeutics Inc. (8AT) stock hit Wall Street targetsWeekly Profit Report & Fast Moving Stock Watchlists - newser.com

02:41 AM
pulisher
12:45 PM

How Aclaris Therapeutics Inc. (8AT) stock performs during market turbulenceJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com

12:45 PM
pulisher
Nov 02, 2025

Using Python tools to backtest Aclaris Therapeutics Inc. strategiesJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why Aclaris Therapeutics Inc. stock attracts global investorsMarket Sentiment Review & Verified Momentum Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can you recover from losses in Aclaris Therapeutics Inc.Rate Cut & Safe Capital Growth Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Aclaris Therapeutics (NASDAQ:ACRS) adds US$40m to market cap in the past 7 days, though investors from three years ago are still down 83% - Yahoo Finance

Nov 02, 2025
pulisher
Nov 02, 2025

How Aclaris Therapeutics Inc. stock trades before earningsWeekly Profit Report & Daily Stock Momentum Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Aclaris Therapeutics Inc. stock a contrarian buy2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How to use a screener to detect Aclaris Therapeutics Inc. breakoutsJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Aclaris Therapeutics Inc. benefit from macro trendsJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Aclaris Therapeutics Inc. (8AT) stock a momentum leaderAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

What drives Aclaris Therapeutics Inc stock priceContrarian Investment Ideas & Investment Recommendations You Can Trust - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Aclaris Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Will Aclaris Therapeutics Inc. (8AT) stock benefit from mergersQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Shares Climb 31% But Its Business Is Yet to Catch Up - 富途牛牛

Oct 31, 2025
pulisher
Oct 31, 2025

Revenues Not Telling The Story For Aclaris Therapeutics, Inc. (NASDAQ:ACRS) After Shares Rise 31% - simplywall.st

Oct 31, 2025
pulisher
Oct 31, 2025

Aclaris Therapeutics’ ATI-045 Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Will Aclaris Therapeutics Inc. stock outperform Dow Jones indexMarket Risk Analysis & Low Risk Investment Opportunities - newser.com

Oct 31, 2025

Aclaris Therapeutics Inc Azioni (ACRS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Aclaris Therapeutics Inc Azioni (ACRS) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Mehra Anand
Director
Nov 19 '24
Buy
2.25
666,666
1,499,998
710,030
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):